.

Arrowhead Research reported $139.44M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Anika Therapeutics ANIK:US $ 91.39M 1.07M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Ligand Pharmaceuticals LGND:US $ 153.22M 138.22M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Moderna Inc MRNA:US 2.87B 2.18B
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Novartis NOVN:VX SF 3625M 10227M
Opko Health OPK:US $ 210.46M 108.18M
Sarepta Therapeutics SRPT:US $ 868.56M 365.31M
Spectrum Pharmaceuticals SPPI:US $ 25.51M 53.17M
Tg Therapeutics TGTX:US $ 231.79M 46.11M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M
Xencor XNCR:US $ 49.41M 28.86M
YTE INCY:US $ 2435.38M 178.62M